Antonin Berthon Email

Machine Learning Researcher . BIOS

Current Roles

Employees:
42
Revenue:
$4.7M
About
BIOS is developing a full-stack neural interface platform, that is optimised to decode and encode the signals from the brain to the body, to treat chronic health conditions. There are three parts to our technology: 1. Our implanted neural interface connects directly with the nerves to isolate the signals that travel between the brain and the body. 2. Our AI decodes and encodes this neural information from hundreds of thousands of individual neurons, tens of thousands of times per second, and sends corrected signals back into the body. 3. Using this neural code, we can build a whole digital healthcare treatment. The BIOS software continuously updates, trains, and enhances the treatment via the cloud. For a person with a severe chronic condition, this means that they can stop worrying about their chronic disease. Their condition will be managed via the nervous system directly by AI, giving personalised and accurate treatments, so that the burden of pills and doctors visits become a second resort rather than a daily reality. Neural interfaces are a powerful new technology that can give us new levels of control over our bodies and lives like never before. BIOS is positioned to provide the neural interface platform on which a new generation of treatments can be built, that can enable millions of people suffering from chronic diseases to improve their quality of life.
BIOS Address
72 Hills Road
Cambridge, null
BIOS Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.